This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Adult fibroblast
Blood
Bone marrow CD34+ cells
Bone marrow-derived mesenchymal stem cell (R14)
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Colon cancer cell (SW48)
Mast cell (HMC-1)
Plasma
Seminal plasma
Serum
By sample status
24 hr culture
72 hr culture
Acute myeloid leukemia
Electroporated with Dicer antibody
High density
Normal
Normal_Exiqon
Pollen allergy_timepoint1
Transplant islets into mouse xenotransplantation-rejected
Type 1 diabetes
Vasectomy
Vasovasostomy
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
3.1e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
3.0e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
3.0e-1
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
4.0e-2
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
3.0e-1
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
3.4e-1
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.
Sci Signal. 2014 Jul 1;7(332):ra63. doi: 10.1126/scisignal.2005231.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
2.2e-6
4.7e-1
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.
Sci Signal. 2014 Jul 1;7(332):ra63. doi: 10.1126/scisignal.2005231.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
3.8e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
4.6e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
3.5e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
6.5e-3
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
1.8e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
5.2e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
5.1e-4
4.6e-1
Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
0.0e+0
3.0e-4
Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing.
RNA Biol. 2016 Oct 28:0.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
6.4e-3
4.6e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000973_2
18
/
0
/
18
hsa-miR-1909-3p
MIMAT0007883
1.4e-3
4.5e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000973_2
18
/
0
/
18
[1]